Valyl-tRNA synthetase (VARS1) (VARS1)

Valine-utilizing enzymes and protein synthesis machinery, primarily represented by Valyl-tRNA synthetase (VARS1), are essential for the translation of genetic code into proteins by facilitating the attachment of valine to its corresponding tRNA (UniProt P26640). This machinery is a fundamental component of the cellular growth apparatus, ensuring that the essential amino acid valine is correctly incorporated into nascent polypeptide chains during ribosomal translation (NCBI Gene 7407). Recent studies have highlighted this pathway as a significant metabolic vulnerability in T-cell acute lymphoblastic leukemia (T-ALL), where leukemic cells demonstrate an exceptional dependency on exogenous valine for survival and proliferation (Thandapani et al., 2021). Therapeutic targeting of this machinery, either through dietary valine restriction or pharmacological inhibition of VARS1, triggers the integrated stress response (ISR), characterized by eIF2alpha phosphorylation and ATF4 induction, ultimately leading to cell cycle arrest and apoptosis (Nature, 2021). Beyond oncology, genetic defects in this machinery are linked to severe neurodevelopmental conditions, including microcephaly and epilepsy, underscoring its vital role in human development (PubMed 30503521). This target group represents a novel frontier in precision nutrition and metabolic therapy for hematologic malignancies.

Other names

Valine--tRNA ligase, cytoplasmicVARSG7AValyl-tRNA synthetase 1Valine-utilizing enzymes and protein synthesis machinery

Inhibition of valine-tRNA ligation, leading to depletion of charged Val-tRNA, stalling of the ribosome, and activation of the integrated stress response (ISR).